Clobazam Suspension
Product Images NDC 62135-527

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 62135-527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label (Clobazam Container Label)

FDA Label Image

Clobazam-figure-1 (Clobazam Figure 1)

Clobazam-figure-1 (Clobazam Figure 1)
The text appears to be a table representing "% Reduction in" with some values for different categories ranging from "-80" to "68.3". The categories include Placebo, Low, Medium, and High. It also includes some symbols like "*", ">", and "<" with values of "p<005" and "p<001".*
FDA Label Image

Clobazam-figure-2 (Clobazam Figure 2)

Clobazam-figure-2 (Clobazam Figure 2)
This text represents a chart or graph showing the percentage of patients in different treatment groups for a certain condition, along with their improvement in weekly drop seizure frequency from baseline. The treatment groups include a Placebo, Clobazam Low, Medium, and High. The chart also shows the range of reduction in weekly drop seizure frequency from baseline.*
FDA Label Image

Clobazam-figure-a (Clobazam Figure A)

FDA Label Image

Clobazam-figure-b (Clobazam Figure B)

FDA Label Image

Clobazam-figure-c (Clobazam Figure C)

FDA Label Image

Clobazam-figure-d (Clobazam Figure D)

FDA Label Image

Clobazam-structure-formula.jpg (Clobazam Structure Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.